Careful Dosage: Miotin should be administered under close clinical observation to:
Patients who have a history of hypersensitivity to macrolide antibiotics, including this drug.
Patients with impaired hepatic function.
Use in pregnancy: Since the safety of its use in pregnancy has not been established, Miotin should not be used in pregnant women or women suspected of being pregnant unless, in the judgment of a physician, the potential benefits outweigh the possible risks.
Use in children: The safety of Miotin in premature infants and newborns has not been established.